Search Within

Michael Morris

  1. "European Journal of Nuclear Medicine and Molecular Imaging"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Solid Tumor Oncology Division (10)
  4. Molecular Imaging and Therapy Service (3)
  5. Radiology, Department of (3)
  6. Center for Pancreatic Cancer Research (2)

More Groups

People
  1. Howard Scher (3)
  2. Neeta Pandit-Taskar (3)
  3. Jeremy Durack (2)
  4. Jorge Carrasquillo (2)
  5. Joseph O'Donoghue (2)
  6. Stephen Solomon (2)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2014 (2)
  6. 2013 (1)

More Years

Publications
  1. European Journal of Nuclear Medicine and Molecular Imaging (10)
Publishers
  1. Springer (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumour dosimetry across 6 cycles of [(177)Lu]LuPSMA-617 in patients with metastatic castrationresistant prostate cancer: Results from the VISION substudy
    Meeting Abstract

    Herrmann, K.; Krause, B.; Chi, K.; Sartor, O.; Fizazi, K.; Morris, M. J.; De Bono, J.; Tagawa, S.; Kurth, J.; Eiber, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Standardized template for clinical reporting of PSMA PET/CT scans
    Journal Article

    Esfahani, S. A.; Morris, M. J.; Sartor, O.; Frydenberg, M.; Fanti, S.; Calais, J.; Vapiwala, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Association of baseline quantitative [68Ga]Ga-PSMA-11 PET imaging parameters with clinical outcomes in patients with mCRPC receiving [177Lu]Lu-PSMA-617: a VISION sub-study
    Meeting Abstract

    Kuo, P. H.; Morris, M.; Kendi, A. T.; Rahbar, K.; Wei, X. X.; Fang, B.; Armstrong, A. J.; Hesterman, J.; Chi, K.; de Bono, J.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQoL), pain and safety outcomes in the phase 3 VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Herrmann, K.; Krause, B. J.; Rahbar, K.; Chi, K. N.; Morris, M. J.; Sartor, O.; Tagawa, S. T.; Kendi, A. T.; Vogelzang, N.; Calais, J.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2022)

    Fulltext@MSK | Save
  • Analytical performance of aPROMISE: Automated anatomic contextualization, detection, and quantification of [(18)F]DCFPyL (PSMA) imaging for standardized reporting
    Journal Article

    Johnsson, K.; Brynolfsson, J.; Sahlstedt, H.; Nickols, N. G.; Rettig, M.; Probst, S.; Morris, M. J.; Bjartell, A.; Eiber, M.; Anand, A.
    European Journal of Nuclear Medicine and Molecular Imaging (2022)

    Fulltext@MSK | Save
  • Phase 3 study of (177)Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)
    Meeting Abstract

    Krause, B.; de Bono, J.; Chi, K. N.; Fizazi, K.; Herrmann, K.; Rahbar, K.; Tagawa, S. T.; Nordquist, L. T.; Vaishampayan, N.; El-Haddad, G.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • Molecular imaging with 89Zr anti-PSMA targeted PET/CT: Percutaneous biopsies of prostate cancer metastasis can be accurately performed without reinjection
    Meeting Abstract

    Cornelis, F.; Durack, J. C.; Pandit-Taskar, N.; Morris, M.; Solomon, S. B.
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save
  • 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save
  • Phase i pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer
    Journal Article

    Carrasquillo, J. A.; O'Donoghue, J. A.; Pandit-Taskar, N.; Humm, J. L.; Rathkopf, D. E.; Slovin, S. F.; Williamson, M. J.; Lacuna, K.; Aksnes, A. K.; Larson, S. M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2013)

    Fulltext@MSK | Save
  • 11C-acetate PET imaging in prostate cancer
    Journal Article

    Morris, M. J.; Scher, H. I.
    European Journal of Nuclear Medicine and Molecular Imaging (2007)

    Fulltext@MSK | Save